807O Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant (advanced or recurrent) ovarian cancer: Open-label, randomized trial in Japan (NINJA trial)

詳細情報 詳細情報について

• CRID

  1873679867502453376

• DOI

  10.1016/j.annonc.2020.08.946

• ISSN

  09237534

• データソース種別

  • OpenAIRE